Á lódáil...
Doripenem Treatment during Continuous Renal Replacement Therapy
Doripenem is a broad-spectrum parenteral carbapenem with enhanced activity against Pseudomonas aeruginosa. While the initial dosing recommendation for renally competent patients and patients undergoing continuous renal replacement therapy (cRRT) was 500 mg every 8 h (q8h), the dose for renally compe...
Na minha lista:
| Foilsithe in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Society for Microbiology
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4775919/ https://ncbi.nlm.nih.gov/pubmed/26711775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01801-15 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|